Fatal pulmonary toxicity resulting from treatment with gemcitabine
- PMID: 9576306
- DOI: 10.1002/(sici)1097-0142(19980501)82:9<1802::aid-cncr33>3.0.co;2-6
Fatal pulmonary toxicity resulting from treatment with gemcitabine
Comment on
-
Fatal pulmonary toxicity resulting from treatment with gemcitabine.Cancer. 1997 Jul 15;80(2):286-91. doi: 10.1002/(sici)1097-0142(19970715)80:2<286::aid-cncr17>3.0.co;2-q. Cancer. 1997. PMID: 9217042
Similar articles
-
[Fatal gemcitabine administration related-pulmonary toxicity].Farm Hosp. 2012 Nov-Dec;36(6):552-3. doi: 10.7399/FH.2012.36.6.39. Farm Hosp. 2012. PMID: 23461454 Spanish. No abstract available.
-
Fatal pulmonary toxicity resulting from treatment with gemcitabine.Cancer. 1997 Jul 15;80(2):286-91. doi: 10.1002/(sici)1097-0142(19970715)80:2<286::aid-cncr17>3.0.co;2-q. Cancer. 1997. PMID: 9217042
-
Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer.Pancreas. 2009 Oct;38(7):838-40. doi: 10.1097/MPA.0b013e3181ad97cf. Pancreas. 2009. PMID: 19893461 No abstract available.
-
Hemolytic-uremic syndrome caused by gemcitabine.Ann Oncol. 1998 Dec;9(12):1355. doi: 10.1023/a:1008467914836. Ann Oncol. 1998. PMID: 9932169 Review. No abstract available.
-
[Asbestos--gemcitabin. Combined risk for pulmonary toxicity?].Rev Mal Respir. 2003 Apr;20(2 Pt 1):187-9. Rev Mal Respir. 2003. PMID: 12844015 Review. French. No abstract available.
Cited by
-
Excellent response to gemcitabine in a massively pre-treated woman with extensive cutaneous involvement after recurrence of breast cancer.Invest New Drugs. 2001;19(1):93-100. doi: 10.1023/a:1006474600525. Invest New Drugs. 2001. PMID: 11291839
-
Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder.J Cancer Res Clin Oncol. 2004 Feb;130(2):122-5. doi: 10.1007/s00432-003-0529-4. Epub 2004 Jan 27. J Cancer Res Clin Oncol. 2004. PMID: 14745551 Free PMC article.
-
A report on serious pulmonary toxicity associated with gemcitabine-based therapy.Invest New Drugs. 2002 Aug;20(3):311-5. doi: 10.1023/a:1016214032272. Invest New Drugs. 2002. PMID: 12201493
-
Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report.World J Clin Cases. 2023 Feb 26;11(6):1372-1378. doi: 10.12998/wjcc.v11.i6.1372. World J Clin Cases. 2023. PMID: 36926125 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical